15年戦争資料 @wiki
安定ヨウ素剤予防服用の考え方・参考文献
最終更新：
pipopipo555jp
-
view
参考文献
1．原爆放射線の人体影響１９９２（放射線被曝者医療国際協力推進協議会編）ｐ60－68，文光堂、東京、1992.
2．Thompson, D.E., et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors,
1958-1987. Radiat Res 137: S17-67, 1994.
3．Ron, E., et al. Thyroid cancer after exposure to external radiation: a pooled analysis
of seven studies. Radiat Res 141:259- 277, 1995.
4．Hamilton, T.E., et al. Thyroid neoplasia in Marshall Islanders exposed to nuclear
fallout. JAMA 258:629-635, 1987.
5．Kazakov, V.S., et al. “Thyroid cancer after Chernobyl” (letter to the editor). Nature
359:21, 1992.
6．Williams, E.D., et al. Effects on the thyroid in populations exposed to radiation as a
result of the Chernobyl accident. In: One decade after Chernobyl: Summing up the
consequence of the accident. Vienna, International Atomic Energy Agency, 207-230, 1996.
7．Pacini, F., et al. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents:
comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin
Endocrinol Metab 82: 3563-3569, 1997.
8．Chernobyl: A Decade (Edited by Yamashita, S., Shibata, Y.) Elsevier, the Netherlands,
1997.
9．Shibata, Y., et al. 15 years after Chernobyl: new evidence of thyroid cancer. Lancet
358:1965-1966, 2001.
10． Ashtakhova, L.N., et al. Chernobyl-related thyroid cancer in children of Belarus: a
case-control study. Radiat Res 150:349-356, 1998.
11． Ivanov, V.K., et al. Dynamics of thyroid cancer incidence in Russia following the
Chernobyl accident. J Radiol Prot 19:305-318, 1999.
12． Hahn, K., et al. Thyroid cancer after diagnostic administration of iodine-131 in
childhood. Radiat Res 156:61-70, 2001.
13． Nagataki, S., et al. Cause of childhood thyroid cancer after the Chernobyl accident.
Thyroid 8:116-117, 1998.
14． Intervention criteria in a nuclear or radiation emergency. IAEA SS 109, Vienna, 1994.15． Guidelines for iodine prophylaxis following nuclear accidents update 1999, WHO,
Geneva, 1999.
16． IAEA/WHO Technical committee meeting to assess and review the international safety
standards for intervention in emergency exposure situations involving radioactive iodine.
IAEA, Vienna, 2001.
17． Robbins, J., et al. Radiation effects in the Marshall Islands. Proceedings of the 27th
annual meeting of the Japanese Nuclear Medicine Society, October 1-3, Nagasaki, Japan,
1987.
18． Nagataki, S., et al. Thyroid diseases among atomic bomb survivors in Nagasaki. JAMA
272:364-370, 1994.
19． Morgan, A., et al. Studies on the retention and metabolism of inhaled methyl
iodide-II. Health Phys 13: 1067-1074, 1967.
20． ICRP Publ. 66. Human respiratory tract model for radiological protection. Annuals of
ICRP24(No.1-3), 1994.
21． ICRP Publ. 30. Limits for intakes of radionuclides by workers. Annuals of ICRP2(3/4).
Part1, 1979.
22． Nagataki, S. The role of iodine in thyroid disease. In: Current problems in thyroid
disease (Edited by Lee, M., Koh, C-S., Cho, B.Y.). Korean Thyroid Society, 1985.
23． ICRP Publ. 56. Age-dependent doses to member of the public form intake of
radionuclides. Part 1. Annuals of ICRP20(2), 1989.
24． Yamashita, S. Personal letter, 2002.
25． Adams, C.A., et al. Administration of stable iodine as a means of reducing thyroid
irradiation resulting from inhalation of radioactive iodine: Health Phys 7:127-149, 1962.
26． Sternthal, E., et al. Suppression of thyroid radioiodine uptake by various doses of
stable iodine, N Engl J Med 303:1083-1088, 1980.
27． Becker, D.V., et al. The use of iodine as a thyroid blocking agent in the event of a
reactor accident. Report of the Environmental Hazards Committee of the American Thyroid
Association. JAMA, 252:659- 661, 1984.
28． FDA/Center for drug evaluation and research. Guidance. Potassium iodide as a thyroid
blocking agent radiation emergencies, December 10, 2001.
29． NCRP. Report No.55. Protection of the thyroid gland in the event and potentially
pregnant women. 1977
30． Nagataki, S. Effect of excess quantities of iodine. In Handbook of Physiology, Section
7: Endocrinology, Volume III. Thyroid. American Physiology Society, Washington, D.C., 1974.
31． Nagataki, S., et al. Other factors regulating thyroid function. In Werner and
Ingbar’s The Thyroid. A fundamental and clinical text. 7th ed. (Edited by Braverman,
L.E., Utiger, R.D.) Lippincott-Raven Publishers, Philadelphia, NY, 1996.
32． The Thyroid, A fundamental and clinical text. 8th ed. (Edited by Braverman, L.E.,
Utiger, R.D.) Lippincott Williams and Wilkins, Philadelphia, NY, 2000.
33． Eng, P.H., et al. Escape from the acute Wolff-Chaikoff effects is associated with a
decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.
Endocrinology 140:3404-3410, 1999.
34． Zanzonico, P.B., et al. Effects of time of administration and dietary iodine levels on
potassium iodide (KI) blockade of thyroid irradiation by I-131 from radioactive fallout.
Health Phys 78: 660- 667,2000.
35． Curd, J.G, et al. Potassium iodide sensitivity in four patients with
hypocomplementemic vasculitis. Ann Intern Med 91:853-857, 1979.
36． 皮膚科学 考え方学び方 山田瑞穂著 金原出版株式会社 1990.
37． Daniels, G.H. Aminodarone-induced thyrotoxicosis. J Clin Endocrinol Metabol 86:3-8,
2001.
38． Martino, E., et al. The effects of aminodarone on the thyroid. Endocr Rev 22:240-254,
2001.
39． Calaciura, F., et al. Childhood IQ measurements in infants with transient congenital
hypothyroidism. Clin Endocrinol 43:473-477,1995.
40． Fisher, D.A. The importance of early management in optimizing IQ in infants with
congenital hypothyroidism. J Pediatr 136:273-274, 2000.
41． Namba, H., et al. Evidence of thyroid volume increase in normal subjects receiving
expose iodide. J Clin Endocrinol Metab 76:605-608, 1993.
42． Nauman, J., et al. Iodine prophylaxis in Porland after the Chernobyl reactor accident:
benefits and risks. Am J Med 94:524-532, 1993.
43． 五訂日本食品成分表；食品成分調査会／編、科学技術庁資源調査会／編 医歯薬出版株式会社2001 年版
44． 治療食必携 監修／名尾良憲、編集／藤本良昭 医歯薬出版株式会社2000年版
45． 横山直方、日本人のヨード摂取量と甲状腺機能、保健物理 30:243-250、1995.
2．Thompson, D.E., et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors,
1958-1987. Radiat Res 137: S17-67, 1994.
3．Ron, E., et al. Thyroid cancer after exposure to external radiation: a pooled analysis
of seven studies. Radiat Res 141:259- 277, 1995.
4．Hamilton, T.E., et al. Thyroid neoplasia in Marshall Islanders exposed to nuclear
fallout. JAMA 258:629-635, 1987.
5．Kazakov, V.S., et al. “Thyroid cancer after Chernobyl” (letter to the editor). Nature
359:21, 1992.
6．Williams, E.D., et al. Effects on the thyroid in populations exposed to radiation as a
result of the Chernobyl accident. In: One decade after Chernobyl: Summing up the
consequence of the accident. Vienna, International Atomic Energy Agency, 207-230, 1996.
7．Pacini, F., et al. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents:
comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin
Endocrinol Metab 82: 3563-3569, 1997.
8．Chernobyl: A Decade (Edited by Yamashita, S., Shibata, Y.) Elsevier, the Netherlands,
1997.
9．Shibata, Y., et al. 15 years after Chernobyl: new evidence of thyroid cancer. Lancet
358:1965-1966, 2001.
10． Ashtakhova, L.N., et al. Chernobyl-related thyroid cancer in children of Belarus: a
case-control study. Radiat Res 150:349-356, 1998.
11． Ivanov, V.K., et al. Dynamics of thyroid cancer incidence in Russia following the
Chernobyl accident. J Radiol Prot 19:305-318, 1999.
12． Hahn, K., et al. Thyroid cancer after diagnostic administration of iodine-131 in
childhood. Radiat Res 156:61-70, 2001.
13． Nagataki, S., et al. Cause of childhood thyroid cancer after the Chernobyl accident.
Thyroid 8:116-117, 1998.
14． Intervention criteria in a nuclear or radiation emergency. IAEA SS 109, Vienna, 1994.15． Guidelines for iodine prophylaxis following nuclear accidents update 1999, WHO,
Geneva, 1999.
16． IAEA/WHO Technical committee meeting to assess and review the international safety
standards for intervention in emergency exposure situations involving radioactive iodine.
IAEA, Vienna, 2001.
17． Robbins, J., et al. Radiation effects in the Marshall Islands. Proceedings of the 27th
annual meeting of the Japanese Nuclear Medicine Society, October 1-3, Nagasaki, Japan,
1987.
18． Nagataki, S., et al. Thyroid diseases among atomic bomb survivors in Nagasaki. JAMA
272:364-370, 1994.
19． Morgan, A., et al. Studies on the retention and metabolism of inhaled methyl
iodide-II. Health Phys 13: 1067-1074, 1967.
20． ICRP Publ. 66. Human respiratory tract model for radiological protection. Annuals of
ICRP24(No.1-3), 1994.
21． ICRP Publ. 30. Limits for intakes of radionuclides by workers. Annuals of ICRP2(3/4).
Part1, 1979.
22． Nagataki, S. The role of iodine in thyroid disease. In: Current problems in thyroid
disease (Edited by Lee, M., Koh, C-S., Cho, B.Y.). Korean Thyroid Society, 1985.
23． ICRP Publ. 56. Age-dependent doses to member of the public form intake of
radionuclides. Part 1. Annuals of ICRP20(2), 1989.
24． Yamashita, S. Personal letter, 2002.
25． Adams, C.A., et al. Administration of stable iodine as a means of reducing thyroid
irradiation resulting from inhalation of radioactive iodine: Health Phys 7:127-149, 1962.
26． Sternthal, E., et al. Suppression of thyroid radioiodine uptake by various doses of
stable iodine, N Engl J Med 303:1083-1088, 1980.
27． Becker, D.V., et al. The use of iodine as a thyroid blocking agent in the event of a
reactor accident. Report of the Environmental Hazards Committee of the American Thyroid
Association. JAMA, 252:659- 661, 1984.
28． FDA/Center for drug evaluation and research. Guidance. Potassium iodide as a thyroid
blocking agent radiation emergencies, December 10, 2001.
29． NCRP. Report No.55. Protection of the thyroid gland in the event and potentially
pregnant women. 1977
30． Nagataki, S. Effect of excess quantities of iodine. In Handbook of Physiology, Section
7: Endocrinology, Volume III. Thyroid. American Physiology Society, Washington, D.C., 1974.
31． Nagataki, S., et al. Other factors regulating thyroid function. In Werner and
Ingbar’s The Thyroid. A fundamental and clinical text. 7th ed. (Edited by Braverman,
L.E., Utiger, R.D.) Lippincott-Raven Publishers, Philadelphia, NY, 1996.
32． The Thyroid, A fundamental and clinical text. 8th ed. (Edited by Braverman, L.E.,
Utiger, R.D.) Lippincott Williams and Wilkins, Philadelphia, NY, 2000.
33． Eng, P.H., et al. Escape from the acute Wolff-Chaikoff effects is associated with a
decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.
Endocrinology 140:3404-3410, 1999.
34． Zanzonico, P.B., et al. Effects of time of administration and dietary iodine levels on
potassium iodide (KI) blockade of thyroid irradiation by I-131 from radioactive fallout.
Health Phys 78: 660- 667,2000.
35． Curd, J.G, et al. Potassium iodide sensitivity in four patients with
hypocomplementemic vasculitis. Ann Intern Med 91:853-857, 1979.
36． 皮膚科学 考え方学び方 山田瑞穂著 金原出版株式会社 1990.
37． Daniels, G.H. Aminodarone-induced thyrotoxicosis. J Clin Endocrinol Metabol 86:3-8,
2001.
38． Martino, E., et al. The effects of aminodarone on the thyroid. Endocr Rev 22:240-254,
2001.
39． Calaciura, F., et al. Childhood IQ measurements in infants with transient congenital
hypothyroidism. Clin Endocrinol 43:473-477,1995.
40． Fisher, D.A. The importance of early management in optimizing IQ in infants with
congenital hypothyroidism. J Pediatr 136:273-274, 2000.
41． Namba, H., et al. Evidence of thyroid volume increase in normal subjects receiving
expose iodide. J Clin Endocrinol Metab 76:605-608, 1993.
42． Nauman, J., et al. Iodine prophylaxis in Porland after the Chernobyl reactor accident:
benefits and risks. Am J Med 94:524-532, 1993.
43． 五訂日本食品成分表；食品成分調査会／編、科学技術庁資源調査会／編 医歯薬出版株式会社2001 年版
44． 治療食必携 監修／名尾良憲、編集／藤本良昭 医歯薬出版株式会社2000年版
45． 横山直方、日本人のヨード摂取量と甲状腺機能、保健物理 30:243-250、1995.
